INCY Incyte

$98.27 -0.73%

Industrials · Services-Commercial Physical & Biological Research

Incyte (INCY) is a industrials company in the Services-Commercial Physical & Biological Research industry, with a market capitalization of $19.6 billion. Shares last traded at $98.27, 12.5% below their 52-week high. Over the past year the stock is up 42.9%. INCY trades at a price-to-earnings ratio of 15.26, below the Services-Commercial Physical & Biological Research median of 24.86. Net profit margin is 25.0%, above the peer median of 8.4%. Revenue grew 21.2% year over year.

Market Cap

$19.6B

Shares Out

199.8M

EPS (TTM)

$10.06

P/E Ratio

9.77

P/S Ratio

3.82

P/B Ratio

3.49

Dividend / Share

—

Dividend Yield

—

52-Week High

$112.29

52-Week Low

$66.84

Volume

69,627

Avg Vol (3m)

75,019.238

Performance

-8.92%

+2.79%

+5.76%

+1.29%

YTD

-3.15%

+42.88%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

46.75

SMA (50)

$98.17

SMA (200)

$96.80

Price vs SMA50

+0.10%

Price vs SMA200

+1.52%

ATR (14)

$3.85

Financials

Revenue

$5.1B

Net Income

$1.3B

Gross Margin

—

Operating Margin

29.5%

Net Margin

25.0%

Return on Equity

22.9%

Return on Assets

17.5%

Current Ratio

3.68

Debt / Equity

3.40

Revenue Growth (YoY)

+21.2%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$1.47	2026-04-28
FY 2025	$6.41	2026-02-10
Q3 2025	$4.95	2025-10-28
Q2 2025	$2.84	2025-07-29
Q1 2026	$0.80	2026-04-28
FY 2025	$0.15	2026-02-10

Full earnings history →

Services-Commercial Physical & Biological Research peers

INCY vs 12 industry peers (Services-Commercial Physical & Biological Research), by market cap.

P/E vs peers

15.26 / 24.86 med

-39% discount

P/S vs peers

3.82 / 3.04 med

+25% premium

Net margin vs peers

25.0% / 8.4% med

above median

1–12 of 12


IQV	IQVIA	$28.0B	20.58	1.72	8.3%	-1.74%
INCY	Incyte	$19.6B	15.26	3.82	25.0%	-0.73%
MEDP	Medpace Holdings, Inc.	$13.1B	29.14	5.19	17.8%	+0.66%
CRL	Charles River Laboratories	$8.9B	-61.77	2.22	-3.6%	+1.47%
ABSI	Absci Corp	$1.2B	-10.00	—	—	+3.07%
NRC	Nrc Health	$418M	36.04	3.04	8.4%	+4.57%
OABI	OmniAb, Inc.	$339M	-5.24	—	—	+15.27%
MXCT	MAXCYTE, INC.	$129M	-2.88	—	—	+5.73%
ONMD	OneMedNet Corp	$31M	-10.93	—	—	-5.21%
BIAF	bioAffinity Technologies, Inc.	$4M	—	—	—	+0.63%
ISPC	iSpecimen Inc.	$4M	-0.36	—	—	+0.38%
ICLR	Icon Plc	—	—	—	2.8%	+1.94%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.